FDA Approves Vision System That Helps Certain Blind Patients Regain Lost Vision

2 Min Read

Portable Vision System

Generally speaking logic says that when you are blind that you cannot
see the world around you. One company, Second Sight Medical Products,
Inc., hopes to change all of that and this week they have made a major
stride forward. Their system, dubbed the Argus II Retinal Prosthesis
System, has been approved for use by the FDA. The device is described by the FDA
in the following terms, "The device, which includes a small video
camera, transmitter mounted on a
pair of eyeglasses, video processing unit (VPU) and an implanted
retinal prosthesis (artificial retina), replaces the function of
degenerated cells in the retina (a membrane inside the eye) and may
improve a patient’s ability to perceive images and movement. The VPU
transforms images from the video camera into electronic data that is
wirelessly transmitted to the retinal prosthesis."

The condition
that the system is designed to treat is known as advanced retinitis
pigmentosa, a relatively rare genetic condition that does damage to
light-sensitive cells that line the retina. The condition is
progressive, beginning by reducing side vision, then night vision and
finally taking the rest of the vision in its advance stage. The study
that gained approval was done on 30 adults, and 19 had no adverse
effects. the device is approved for patients 25 years or older.

Image Source: Second Site

See also  Chris Hughes Using Social Media Engagement To Expand 'The Good Web'

Why Trust InventorSpot

Our team of innovation experts take great pride in the quality of our content. Our writers create original, accurate, engaging content that is free of ethical concerns or conflicts. Our rigorous editorial process includes editing for accuracy, recency, and clarity.

Share This Article
This is the archive of InventorSpot. These articles were created from 2000-2020 from various previous authors over the years. Please note: they are no longer being updated and refreshed. We thank the previous authors for their contributions to the publication over the years.